Two-thirds of high severity likely due to upcoding, according to a RAND study of hospitalizations in five states.
Upcoding is one of the biggest bones of contention between U.S. payers and providers, which in this context are mainly hospitals. Payers say providers upcode to higher severity levels with little, if any, medical justification as a way to increase payment levels. Providers counter that the patients that they are taking care of are sicker and that coding at a higher severity is warranted.
In this back-and-forth, the results from a RAND study published in Health Affairs put some persuasive evidence behind the argument that payers have been making.
Daniel Crespin, Ph.D., M.S.P.H., a policy researcher at RAND and lead author of the study, and his colleagues had access to hospital inpatient databases prepared by the Healthcare Cost and Utilization Project for Florida, Kentucky, New York, Washington state, and Wisconsin.
They found that the discharges with the highest severity level increased from 17.2 per 1,000 population in 2011 to 24.2 per 1,000 population in 2019, a 41% increase. When they factored in patient characteristics, length of stay and hospital characteristics, they estimated that the increase would have been just 13%. Put another way, Crespin and his colleagues found that only one-third of the increase in severity could be explained by “observable” discharge and patient and hospital characteristics, and that the remaining two-thirds could be chalked up to upcoding.
The RAND researchers calculated that payments to hospitals associated with upcoding reached $40.6 billion in 2019, which works out to be 1.1% of all U.S. healthcare payments. Medicare payments associated with upcoding came to $11.6 billion in 2019, which the researchers noted is approximately the same as the Medicare Payment Advisory Commission’s estimate of the upcoded health-risk payments to Medicare Advantage plans that same year.
The results from this RAND study were were published in early December 2024 in Health Affairs.
Trump Administration Throws U.S. AIDS Support into Turmoil
February 6th 2025PEPFAR, the main U.S.-funded global AIDS program was given a waiver from the foreign aid freeze, but there is still uncertainty and interruptions, partly because many PEPFAR programs are implemented through USAID, which has been largely shutdown by the news administration.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen